MINNEAPOLIS, May 31, 2024 /PRNewswire/ — Bio-Techne Corporation (NASDAQ: TECH) today announced that Kim Kelderman, President and Chief Executive Officer…
Solutions enable both research and clinical teams with precision oncology, accelerating clinical trials, increasing patient access, and driving improved patient outcomes…